This paper is only available as a PDF. To read, Please Download here.
Summary
The results are presented of a controlled trial comparing high dosage penicillin (3
mega units twice daily) with penicillin 1 mega unit twice daily plus streptomycin 0·5 g. twice daily, in the treatment of exacerbations of bronchitis,
the treatment regimen being allocated at random. The clinical composition in the two
groups was similar.
Assessment of the efficiency of therapy was judged by the conversion of the sputum
to mucoid on the seventh and fourteenth day.
Sputum conversion occurred by the seventh day in 30 of the 36 patients (83 per cent.)
treated with high dosage penicillin, as compared with 24 out of 40 patients (60 per
cent.) treated with penicillin plus streptomycin. The superiority of the high dosage penicillin regimen is statistically
significant.
Only 1 of the 17 cases whose sputum became mucoid on high dosage penicillin and 2
in whom this was achieved on penicillin plus streptomycin relapsed during the second week of therapy.
Only 1 patient complained of more than slight pain on injection; he was on high dosage
penicillin.
Ten patients were treated for 1 week by Neodiazine, an aerosol containing neomycin
plus sulphadiazine. In only 5 of these patients was the sputum converted to mucoid by
the seventh day. Two of these 5 patients received treatment for a second week. In
both cases the sputum was purulent on the fourteenth day. Following these poor results,
Neodiazine treatment was discontinued.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Respiratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Brit. med. J. 1951; i: 554
- Brit. med. J. 1957; i: 1444
- Lancet. 1957; ii: 214
- 9th ed. Textbook of Medical Treatment. E. & S. Livingstone, Chicago1963: 681
- Lancet. 1953; ii: 903
- Aust. Ann. Med. 1961; 10: 275
Hafez, F., Stewart, Sheila M., & Burnet, M. Eileen (1964). In press.
- Acta Path. Microbiol. Scan. 1962; 55: 79
- Lancet. 1953; ii: 534
- Lancet. 1953; ii: 899
- Acta med. scand. 1952; 143: 32
- Brit. med. J. 1959; ii: 1277
- Quart. J. Med. 1953; 46: 121
- Brit. med. J. 1953; ii: 1069
Article info
Footnotes
The research was partly supported by a grant from the Royal Victoria Hospital Tuberculosis Trust. Some of the cases were under the care of Dr. A. P. Littlewood, East Fortune Hospital, East Lothian.
Identification
Copyright
© 1965 Ballière, Tindalli & Cassell. Published by Elsevier Inc.
